The Shingles Vaccine, Explained

If you had chickenpox as a child, and almost everyone born before 1980 did, the virus never left. It has been sitting quietly in your nerve roots for decades, held down by your immune system. Shingles is what happens when that grip loosens, and the odds of it happening climb steadily from your 50s onward.

There is now a vaccine good enough that I bring it up unprompted with almost every patient over 50. It is also a vaccine with a genuinely sore arm and a real chance of a rough day afterward, and people deserve to hear that plainly rather than discover it. Here is the whole picture.

What shingles actually is#

Chickenpox is caused by the varicella-zoster virus. When the childhood illness ends, the virus retreats up the sensory nerves and goes dormant in clusters of nerve cells beside the spinal cord and in the head. It stays there for life.

Decades later, if the immune surveillance keeping it dormant weakens, the virus can reactivate. It travels back down a single sensory nerve to the skin, which is why shingles appears as a painful, blistering rash in a band or patch on one side of the body, most often the torso, sometimes the face. Many people feel burning, tingling, or stabbing pain in the area for several days before anything appears on the skin. The rash blisters, crusts over within a week to ten days, and generally heals over two to four weeks.

If the story ended there, shingles would be a miserable few weeks. Two complications make it more than that:

• Postherpetic neuralgia (PHN). In roughly 10 to 18 percent of cases, the nerve pain persists for months or years after the rash heals. Skin that hurts at the brush of clothing, sleep destroyed, and pain that is notoriously hard to treat once established. PHN risk rises sharply with age; it is uncommon under 40 and the main threat over 70.
• Eye involvement. When the virus reactivates in the nerve serving the forehead and eye, in roughly 10 to 20 percent of cases, it can inflame and scar the cornea and threaten sight. A rash on the nose or forehead, or any eye symptoms with shingles, is a same-day medical problem.

Antiviral medicines help most when started within about 72 hours of the rash appearing, which is why early recognition matters. They are prescription treatments to discuss with your own doctor, and they blunt the illness rather than erase it. Prevention does more.

Why risk climbs after 50#

The virus is held in check mainly by T cells, the arm of your immune system that hunts infected cells. T-cell immunity ages faster and more noticeably than antibody immunity, a process called immunosenescence. From roughly age 50 the specific T-cell response against varicella-zoster declines, and the reactivation risk curve turns upward, steepening again through the 60s and 70s.

The numbers: about 1 in 3 people will develop shingles in their lifetime, around a million cases a year in the US, and both the likelihood of shingles and the likelihood that it leads to PHN rise with age. Anything else that suppresses T-cell immunity adds to the risk at any age: certain cancers and their treatments, medicines that suppress the immune system after transplants or for autoimmune disease, HIV, and severe illness or major physiological stress. This is why "shingles after a terrible year" is such a common story; significant stress and illness genuinely can tip a borderline immune hold.

The vaccine and its numbers#

The current vaccine is a recombinant, non-live vaccine (sold in the US under the brand name most people have seen advertised, Shingrix). It contains no live virus at all, just one purified viral protein combined with an adjuvant, an ingredient that deliberately provokes a strong immune response. That design has two consequences: it cannot cause shingles, and it works unusually well in exactly the older immune systems that need it.

It is given as two doses into the upper arm, normally 2 to 6 months apart. The trial results, from studies involving more than 30,000 adults, are worth quoting because they are among the best of any adult vaccine:

• About 97 percent effective against shingles in adults 50 to 69.
• About 91 percent effective in adults 70 and older, the group where older vaccines faded badly.
• About 89 to 91 percent effective against PHN, which is arguably the outcome that matters most.
• Long-term follow-up shows protection is durable, staying near 90 percent at seven years and above 80 percent a decade out. No routine booster is currently recommended.

For comparison, the older live vaccine used until 2020 was about 51 percent effective and waned within several years. It is no longer available in the US, and people who received it are advised to be revaccinated with the recombinant vaccine.

The side effects, honestly#

This vaccine's strong immune stimulation is why it works, and it is also why the aftermath is more noticeable than a flu shot. The honest summary:

• A sore arm is near-universal, often sore enough to notice for two or three days.
• Many people get fatigue, muscle aches, headache, shivering, fever, or an upset stomach for a day or two.
• About 1 in 6 people have reactions strong enough to interfere with normal activities for a day or two: the feeling of a short, self-limited flu.
• Symptoms typically appear within a day of the shot and resolve within two to three days. The second dose is at least as likely to do this as the first.
• Serious reactions are rare. Severe allergic reactions occur, as with any vaccine, at a rate of a few per million doses, which is why you wait briefly after the shot. Observational data in older adults suggest a small possible excess of Guillain-Barre syndrome, on the order of a few cases per million doses; regulators concluded the benefit clearly outweighs this.

My practical advice is scheduling, not stoicism. Do not book a dose the day before a long drive, a flight, a wedding, or a heavy shift. Take it when the following day can be an easy one. People tolerate a predicted rough day far better than a surprise one, and the trade, one or two rough days per dose against months of nerve pain, is not close.

Who should ask about it#

A few notes on that table. No blood test for chickenpox immunity is needed first. Other adult vaccines can generally be given around the same time. And if you are in your 40s with an immune-suppressing condition or treatment, you may qualify earlier than 50, which is a question for the doctor who manages that condition.

On cost and access, kept general because plans and countries differ: in the US the vaccine is widely available at pharmacies, and most insurance, including Medicare drug coverage, now covers recommended adult vaccines without out-of-pocket cost, but confirm with your own plan and pharmacy before assuming. Elsewhere, national programs often fund it for specific age bands. If cost is the barrier, ask the pharmacy about manufacturer or public assistance programs rather than simply going without.

At work#

Shingles has a workplace dimension people rarely consider until it happens. A worker with shingles is not spreading shingles, but blister fluid can give chickenpox to anyone non-immune, so the rule I apply on site is simple: rash covered with a dry dressing until fully crusted, scrupulous hand hygiene, and no work near pregnant colleagues, newborns, or immunocompromised people until then. Most people with mild shingles and a coverable rash can keep working if they feel well enough; the pain and fatigue, not contagion, are what usually decide it.

The other half is vaccination logistics. An industrial workforce skews male and over 50, exactly the group least likely to visit a doctor unprompted, so I raise the vaccine at routine medicals and we schedule doses at the start of rest days, never before safety-critical shifts, because a feverish, aching operator is a hazard we can avoid with a calendar. If your employer runs flu clinics, asking them to add shingles vaccination for over-50s is a reasonable request.

What I actually see#

Two patterns repeat. The first is the person who thought shingles was trivial because their only reference was a mild case in a young colleague, and who then watches a parent in their 70s develop PHN and spend a year unable to bear a shirt on their skin. The severity of this disease is very unevenly distributed, and age is the main thing that distributes it.

The second is the person who had dose one, felt lousy for a day, and quietly never returned. I now tell everyone at dose one: the second dose will probably feel similar, it is the price of the 90-plus percent protection, and we will book it today for a quiet week. Framed as a known cost rather than a malfunction, almost everyone completes the course.

The bottom line#

Shingles is a reactivation of a virus you almost certainly already carry, the risk turns upward from age 50, and its worst outcome is nerve pain that can outlast the rash by years. The two-dose recombinant vaccine prevents roughly 9 in 10 or more cases and a similar share of PHN, with protection that lasts at least a decade, and its main cost is a sore arm and, for about 1 in 6 people, a rough day or two per dose. If you are 50 or older, or younger with a weakened immune system, it belongs on your list for your next doctor or pharmacy visit. And a shingles rash near the eye, or shingles with confusion or weakness, is not a wait-and-see situation; get seen the same day.